Cargando…

Does health technology assessment compromise access to pharmaceuticals?

In response to rapidly rising pharmaceutical costs, many countries have introduced health technology assessment (HTA) as a ‘fourth hurdle’. We evaluated the causal effect of HTA based regulation on access to pharmaceuticals by using the introduction of Germany’s HTA system (AMNOG) in 2011. We obtain...

Descripción completa

Detalles Bibliográficos
Autores principales: Büssgen, Melanie, Stargardt, Tom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406713/
https://www.ncbi.nlm.nih.gov/pubmed/37336862
http://dx.doi.org/10.1007/s10198-023-01611-9